Table 3 The comparison of extent and severity of inflammation and fibrosis in pathology between the experimental and control groups.
Experimental group | Control group | P-value | |
|---|---|---|---|
Inflammation extent, n (%) | |||
none | 0 (0%) | 0 (0%) | < 0.001 |
< 25% | 0 (0%) | 9 (90%) | |
25–50% | 3 (30%) | 1 (10%) | |
> 50% | 7 (70%) | 0 (0%) | |
Inflammation severity, n (%) | |||
none | 0 (0%) | 0 (0%) | 0.019 |
mild | 5 (50%) | 8 (80%) | |
moderate | 5 (50%) | 2 (20%) | |
severe | 0 (0%) | 0 (0%) | |
Pathologic inflammation score | 4.80 ± 1.14 | 2.30 ± 0.48 | < 0.001 |
Fibrosis extent, n (%) | |||
none | 2 (20%) | 5 (50%) | 0.35 |
< 25% | 8 (80%) | 5 (50%) | |
25–50% | 0 (0%) | 0 (0%) | |
> 50% | 0 (0%) | 0 (0%) | |
Fibrosis severity, n (%) | |||
none | 2 (20%) | 5 (50%) | 0.067 |
mild | 4 (40%) | 5 (50%) | |
moderate | 4 (40%) | 0 (0%) | |
severe | 0 (0%) | 0 (0%) | |
Pathologic fibrosis score | 2.00 ± 1.16 | 1.00 ± 1.05 | 0.042 |
